SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-028608
Filing Date
2021-05-24
Accepted
2021-05-24 09:14:58
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_cmlifesciences.htm 10-Q 278082
2 CERTIFICATION f10q0321ex31-1_cmlifesci.htm EX-31.1 11550
3 CERTIFICATION f10q0321ex31-2_cmlifesci.htm EX-31.2 11543
4 CERTIFICATION f10q0321ex32-1_cmlifesci.htm EX-32.1 4092
5 CERTIFICATION f10q0321ex32-2_cmlifesci.htm EX-32.2 4411
  Complete submission text file 0001213900-21-028608.txt   2165369

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cmlf-20210331.xml EX-101.INS 246166
7 XBRL SCHEMA FILE cmlf-20210331.xsd EX-101.SCH 38562
8 XBRL CALCULATION FILE cmlf-20210331_cal.xml EX-101.CAL 14723
9 XBRL DEFINITION FILE cmlf-20210331_def.xml EX-101.DEF 161143
10 XBRL LABEL FILE cmlf-20210331_lab.xml EX-101.LAB 277704
11 XBRL PRESENTATION FILE cmlf-20210331_pre.xml EX-101.PRE 163955
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39482 | Film No.: 21951470
SIC: 8000 Services-Health Services